Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Online Access: | https://doi.org/10.1186/s13023-024-03136-7 |
| _version_ | 1797247014602276864 |
|---|---|
| author | Catherine Mease Kathleen L. Miller Lewis J. Fermaglich Jeanine Best Gumei Liu Erika Torjusen |
| author_facet | Catherine Mease Kathleen L. Miller Lewis J. Fermaglich Jeanine Best Gumei Liu Erika Torjusen |
| author_sort | Catherine Mease |
| collection | DOAJ |
| first_indexed | 2024-04-24T19:51:58Z |
| format | Article |
| id | doaj.art-a768d1046fc34402a4219fc4eeee499f |
| institution | Directory Open Access Journal |
| issn | 1750-1172 |
| language | English |
| last_indexed | 2024-04-24T19:51:58Z |
| publishDate | 2024-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Orphanet Journal of Rare Diseases |
| spelling | doaj.art-a768d1046fc34402a4219fc4eeee499f2024-03-24T12:33:43ZengBMCOrphanet Journal of Rare Diseases1750-11722024-03-011911110.1186/s13023-024-03136-7Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug developmentCatherine Mease0Kathleen L. Miller1Lewis J. Fermaglich2Jeanine Best3Gumei Liu4Erika Torjusen5Office of Orphan Products Development, Office of the Commissioner, US Food and Drug AdministrationOffice of Orphan Products Development, Office of the Commissioner, US Food and Drug AdministrationOffice of Orphan Products Development, Office of the Commissioner, US Food and Drug AdministrationOffice of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug AdministrationOffice of Therapeutic Products, Center for Biologics Evaluation and Research, US Food and Drug AdministrationOffice of Orphan Products Development, Office of the Commissioner, US Food and Drug Administrationhttps://doi.org/10.1186/s13023-024-03136-7 |
| spellingShingle | Catherine Mease Kathleen L. Miller Lewis J. Fermaglich Jeanine Best Gumei Liu Erika Torjusen Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development Orphanet Journal of Rare Diseases |
| title | Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development |
| title_full | Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development |
| title_fullStr | Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development |
| title_full_unstemmed | Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development |
| title_short | Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development |
| title_sort | correction to analysis of the first ten years of fda s rare pediatric disease priority review voucher program designations diseases and drug development |
| url | https://doi.org/10.1186/s13023-024-03136-7 |
| work_keys_str_mv | AT catherinemease correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment AT kathleenlmiller correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment AT lewisjfermaglich correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment AT jeaninebest correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment AT gumeiliu correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment AT erikatorjusen correctiontoanalysisofthefirsttenyearsoffdasrarepediatricdiseasepriorityreviewvoucherprogramdesignationsdiseasesanddrugdevelopment |